Ascendis Pharma A (ASND) Cost of Revenue (2021 - 2026)
Ascendis Pharma A's Cost of Revenue was $32.15 million in the quarter ended Jun 30, 2026, down 9.7% from $35.6 million a year earlier but up 56.8% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Cost of Revenue (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's Cost of Revenue was $106.26 million through Jun 30, 2026, up 30.7% year-over-year; for the year ended Dec 31, 2025, it came in at $132.18 million, up 166.8% from the prior year.
- Cost of Revenue has now increased for four consecutive years, with a four-year compound annual growth rate of 139.3% (years ended Dec 2021 to Dec 2025).
- In earlier years, Cost of Revenue was $49.55 million in the year ended Dec 31, 2024 (+3.2%), $48.02 million in the year ended Dec 31, 2023 (+275.4%), $12.79 million in the year ended Dec 31, 2022 (+217.4%) and $4.03 million in the year ended Dec 31, 2021.
- Quarterly Cost of Revenue has moved between $989,535 (the quarter ended Dec 31, 2021) and $58.86 million (the quarter ended Dec 31, 2023) over five years.
- Compared with a year earlier, Cost of Revenue was higher in six of the last eight quarters, with growth averaging 61.0%.
- The best year-over-year quarter for Cost of Revenue over five years was the quarter ended Dec 31, 2022 (growth of 427.0%); the worst was the quarter ended Dec 31, 2024 (a decline of 74.5%).
- Per Business Quant data, ASND's Cost of Revenue in the three quarters before the quarter ended Jun 30, 2026 was $20.51 million (quarter ended Mar 31, 2026), $27.47 million (quarter ended Dec 31, 2025) and $26.13 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Ascendis Pharma A | 15.08 Bn | 11.35 Bn | 362.22 Mn | 32.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.15 Mn |
| Mar 31, 2026 | 20.51 Mn |
| Dec 31, 2025 | 27.47 Mn |
| Sep 30, 2025 | 26.13 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Mar 31, 2025 | 18.43 Mn |
| Dec 31, 2024 | 14.98 Mn |
| Sep 30, 2024 | 12.30 Mn |
| Jun 30, 2024 | 12.35 Mn |
| Mar 31, 2024 | 8.22 Mn |
| Dec 31, 2023 | 20.93 Mn |
| Sep 30, 2023 | 8.04 Mn |
| Jun 30, 2023 | 14.08 Mn |
| Mar 31, 2023 | 4.96 Mn |
| Dec 31, 2022 | 5.22 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 4.77 Mn |
| Dec 31, 2021 | 4.03 Mn |
API Access
Ascendis Pharma A Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();